RSV

RSV

FDA approves RSV maternal vaccine; The latest health stories from around the world

Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi  The U.S. Food and Drug Administration (FDA) has approved a vaccine given to pregnant women to protect babies from respiratory syncytial virus (RSV). The virus causes severe lung infections that are the leading cause of U.S. infant hospitalizations. https://www.science.org/content/article/rsv-vaccine-scientific-advisory-panels-and-biodiversity-hot-spot-risk?   Pregnant people […]

FDA approves RSV maternal vaccine; The latest health stories from around the world Read More »

RSV

FDA approves new RSV vaccine; The latest health stories from around the world

Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi A panel advising the U.S. Food and Drug Administration (FDA) last week recommended that it approve a vaccine given to pregnant people to protect infants from respiratory syncytial virus (RSV), which can cause severe lung infections. https://www.science.org/content/article/news-glance-china-s-ethics-oversight-arpa-h-s-new-science-and-210-million-protein? The vote was unanimous

FDA approves new RSV vaccine; The latest health stories from around the world Read More »

WHO declares end to global mpox emergency; The latest health stories from around the world

Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The World Health Organization (WHO) ended the global health emergency for mpox, on 11 May, 10 months after it was declared, as cases have fallen dramatically in Europe and the Americas. www.science.org/content/article/who-ends-mpox-emergency? Caused by the monkeypox virus (MPXV), the painful and

WHO declares end to global mpox emergency; The latest health stories from around the world Read More »

Triple threat of viral diseases threatens northern hemisphere this winter

Triple threat. Tripledemic. A viral perfect storm. These frightening phrases have dominated recent headlines as some health officials, clinicians, and scientists forecast that SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) could surge at the same time in northern hemisphere locales that have relaxed masking, social distancing, and other COVID-19 precautions. https://www.science.org/content/article/competition-between-respiratory-viruses-may-hold-tripledemic-winter? But a growing body

Triple threat of viral diseases threatens northern hemisphere this winter Read More »

Pfizer announces promising results for RSV vaccine

Barney Graham, a former scientist at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), was thrilled when Pfizer announced encouraging results from an experimental vaccine that could protect against a major childhood killer. In a press release, the company said immunizing pregnant women with its vaccine against respiratory syncytial virus (RSV) protected their babies from severe

Pfizer announces promising results for RSV vaccine Read More »